Henry Schein 2012 Annual Report Download - page 43
Download and view the complete annual report
Please find page 43 of the 2012 Henry Schein annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.33
Years ended
December 29, December 31, December 25, December 26, December 27,
2012 2011 2010 2009 2008
(in thousands)
Net Sales by Market Data:
Health care distribution (3):
Dental ...............................................................
.
$ 4,774,482 $4,764,898 $4,415,469 $4,177,101 $ 4,154,072
Medical .............................................................
.
1,560,921 1,504,454 1,373,999 1,312,750 1,271,289
Animal health ...................................................
.
2,321,151 2,010,270 1,537,370 875,277 791,763
Total health care distribution ........................
.
8,656,554 8,279,622 7,326,838 6,365,128 6,217,124
Technology and value-added services (4) ..........
.
283,413 250,620 199,952 173,208 163,289
Total ..............................................................
.
$ 8,939,967 $8,530,242 $7,526,790 $6,538,336 $ 6,380,413
As of
December 29, December 31, December 25, December 26, December 27,
2012 2011 2010 2009 2008
(in thousands)
Balance Sheet data:
Total assets ..........................................................
.
$ 5,333,997 $4,740,144 $4,547,471 $3,835,985 $ 3,599,210
Long-term debt ....................................................
.
488,121 363,524 395,309 243,373 256,648
Redeemable noncontrolling interests ..................
.
435,175 402,050 304,140 178,570 233,035
Stockholders' equity ............................................
.
2,615,864 2,433,623 2,412,957 2,161,508 1,772,354
(1) Restructuring costs for the year ended December 29, 2012 consist primarily of severance costs, including severance pay and benefits
of $12.8 million and facility closing costs of $2.4 million. Restructuring costs for the year ended December 25, 2010 consist
primarily of severance costs, including severance pay and benefits of $8.9 million and facility closing costs of $3.4 million.
Restructuring costs for the year ended December 26, 2009 consist primarily of employee severance costs, including severance pay
and benefits of $1.5 million and facility closing costs of $1.5 million. Restructuring costs for the year ended December 27, 2008
consist primarily of employee severance costs, including severance pay and benefits of $19.4 million and facility closing costs of
$3.8 million. See “Management’ s Discussion and Analysis of Financial Condition and Results of Operations – Plans of
Restructuring” herein and the consolidated financial statements and related notes contained in ITEM 8.
(2) On August 5, 2009, we completed the sale of a wholesaler of dental consumables for aggregate consideration of $14.2 million, of
which $13.2 million had been received as of December 26, 2009. As a result of this sale, included in operating results from
discontinued operations for 2009 is a net gain, net of tax, of $2.6 million or $0.03 per diluted share.
During the fourth quarter of 2008, included in operating results from discontinued operations, we recorded an impairment charge of
$11.2 million ($7.3 million, net of tax), or $0.08 per diluted share, related to the exit from our wholesale ultrasound business.
(3) Consists of consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and
generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
(4) Consists of practice management software and other value-added products, which are distributed primarily to health care providers,
and financial and other services, including e-services and continuing education services for practitioners.